| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 1.09 MB | Adobe PDF |
Advisor(s)
Abstract(s)
The newly-synthesized lysosomal enzymes travel to the trans-Golgi network
(TGN) and are then driven to the acidic organelle. While the best-known
pathway for TGN-to-endosome transport is the delivery of soluble
hydrolases by the M6P receptors (MPRs), additional pathways do exist, as
showed by the identification of two alternative receptors: LIMP-2,
implicated in the delivery of β-glucocerebrosidase; and sortilin, involved in
the transport of the sphingolipid activator proteins prosaposin and GM2AP,
acid sphingomyelinase and cathepsins D and H. Disruption of the
intracellular transport and delivery pathways to the lysosomes may result in
lysosomal dysfunction, predictably leading to a range of clinical
manifestations of lysosomal storage diseases. However, for a great
percentage of patients presenting such manifestations, no condition is
successfully diagnosed. To analyse if, in this group, phenotypes could be
determined by impairments in the known M6P-independent receptors, we
screened the genes that encode for LIMP-2 and sortilin. No pathogenic
mutations were identified. Other approaches will be needed to clarify
whether sortilin dysfunction may cause disease.
Description
Keywords
Doenças Genéticas Genética Humana Doenças Lisossomais de Sobrecarga LIMP-2 M6P Independent Trafficking Lysosomal Storage Diseases Sortilin
Pedagogical Context
Citation
Clin Genet. 2014 Aug 4. doi: 10.1111/cge.12469. Epub 2014 Sep 17.
Publisher
John Wiley & Sons Ltd.
